469 related articles for article (PubMed ID: 16615112)
21. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
[TBL] [Abstract][Full Text] [Related]
22. Participation behaviour following a false positive test in the Copenhagen mammography screening programme.
Andersen SB; Vejborg I; von Euler-Chelpin M
Acta Oncol; 2008; 47(4):550-5. PubMed ID: 18465321
[TBL] [Abstract][Full Text] [Related]
23. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
[TBL] [Abstract][Full Text] [Related]
24. Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study.
Warner E; Causer PA; Wong JW; Wright FC; Jong RA; Hill KA; Messner SJ; Yaffe MJ; Narod SA; Plewes DB
Breast J; 2011; 17(1):9-17. PubMed ID: 21251121
[TBL] [Abstract][Full Text] [Related]
25. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk.
Podo F; Sardanelli F; Canese R; D'Agnolo G; Natali PG; Crecco M; Grandinetti ML; Musumeci R; Trecate G; Bergonzi S; De Simone T; Costa C; Pasini B; Manuokian S; Spatti GB; Vergnaghi D; Morassut S; Boiocchi M; Dolcetti R; Viel A; De Giacomi C; Veronesi A; Coran F; Silingardi V; Turchett D; Cortesi L; De Santis M; Federico M; Romagnoli R; Ferrari S; Bevilacqua G; Bartolozzi C; Caligo MA; Cilotti A; Marini C; Cirillo S; Marra V; Martincich L; Contegiacomo A; Pensabene M; Capuano I; Burgazzi GB; Petrillo A; Bonomo L; Carriero A; Mariani-Costantini R; Battista P; Cama A; Palca G; Di Maggio C; D'Andrea E; Bazzocchi M; Francescutti GE; Zuiani C; Londero V; Zunnui I; Gustavino C; Centurioni MG; Iozzelli A; Panizza P; Del Maschio A
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):115-24. PubMed ID: 12585665
[TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance imaging as a diagnostic tool for breast cancer in premenopausal women.
Wright H; Listinsky J; Rim A; Chellman-Jeffers M; Patrick R; Rybicki L; Kim J; Crowe J
Am J Surg; 2005 Oct; 190(4):572-5. PubMed ID: 16164923
[TBL] [Abstract][Full Text] [Related]
27. Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization--design and objectives of the Diagnosis Optimisation Study (DIOS).
Kluttig A; Trocchi P; Heinig A; Holzhausen HJ; Taege C; Hauptmann S; Boecker W; Decker T; Loening T; Schmidt-Pokrzywniak A; Thomssen C; Lantzsch T; Buchmann J; Stang A
BMC Cancer; 2007 Jun; 7():100. PubMed ID: 17570833
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of mass screening for breast cancer in the Somme district (France) between 1990 and 1996].
Ganry O; Peng J; Dubreuil A
Rev Epidemiol Sante Publique; 1999 Sep; 47(4):335-41. PubMed ID: 10519174
[TBL] [Abstract][Full Text] [Related]
29. Breast MRI wire-guided excisional biopsy: specimen size as compared to mammogram wire-guided excisional biopsy and implications for use.
Javid SH; Carlson JW; Garber JE; Birdwell RL; Lester S; Lipsitz S; Golshan M
Ann Surg Oncol; 2007 Dec; 14(12):3352-8. PubMed ID: 17849165
[TBL] [Abstract][Full Text] [Related]
30. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.
Granader EJ; Dwamena B; Carlos RC
Acad Radiol; 2008 Dec; 15(12):1590-5. PubMed ID: 19000876
[TBL] [Abstract][Full Text] [Related]
31. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
Leach MO; Boggis CR; Dixon AK; Easton DF; Eeles RA; Evans DG; Gilbert FJ; Griebsch I; Hoff RJ; Kessar P; Lakhani SR; Moss SM; Nerurkar A; Padhani AR; Pointon LJ; Thompson D; Warren RM;
Lancet; 2005 May 21-27; 365(9473):1769-78. PubMed ID: 15910949
[TBL] [Abstract][Full Text] [Related]
32. [Breast self-examination also valuable in women participating in a screening programme].
Zonderhuis BM; Meijer S; Been J; Groot JJ; Langenhorst F; van den Tol MP
Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2341-5. PubMed ID: 19024066
[TBL] [Abstract][Full Text] [Related]
33. Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.
Kriege M; Brekelmans CT; Obdeijn IM; Boetes C; Zonderland HM; Muller SH; Kok T; Manoliu RA; Besnard AP; Tilanus-Linthorst MM; Seynaeve C; Bartels CC; Kaas R; Meijer S; Oosterwijk JC; Hoogerbrugge N; Tollenaar RA; Rutgers EJ; de Koning HJ; Klijn JG
Breast Cancer Res Treat; 2006 Nov; 100(1):109-19. PubMed ID: 16791481
[TBL] [Abstract][Full Text] [Related]
34. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark.
Utzon-Frank N; Vejborg I; von Euler-Chelpin M; Lynge E
Cancer Epidemiol; 2011 Oct; 35(5):393-8. PubMed ID: 21239242
[TBL] [Abstract][Full Text] [Related]
35. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R
Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
[TBL] [Abstract][Full Text] [Related]
36. High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene).
Kuhl CK
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):103-6. PubMed ID: 12585663
[TBL] [Abstract][Full Text] [Related]
37. MRI of the breast as part of the assessment in population-based mammography screening.
Bick U; Engelken F; Diederichs G; Dzyuballa R; Ortmann M; Fallenberg EM
Rofo; 2013 Sep; 185(9):849-56. PubMed ID: 23740312
[TBL] [Abstract][Full Text] [Related]
38. BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.
Rijnsburger AJ; Obdeijn IM; Kaas R; Tilanus-Linthorst MM; Boetes C; Loo CE; Wasser MN; Bergers E; Kok T; Muller SH; Peterse H; Tollenaar RA; Hoogerbrugge N; Meijer S; Bartels CC; Seynaeve C; Hooning MJ; Kriege M; Schmitz PI; Oosterwijk JC; de Koning HJ; Rutgers EJ; Klijn JG
J Clin Oncol; 2010 Dec; 28(36):5265-73. PubMed ID: 21079137
[TBL] [Abstract][Full Text] [Related]
39. The evaluation of women with familial risk of breast cancer.
Boetes C
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):97-101. PubMed ID: 12585662
[TBL] [Abstract][Full Text] [Related]
40. Fusion of MRI and sonography image for breast cancer evaluation using real-time virtual sonography with magnetic navigation: first experience.
Nakano S; Yoshida M; Fujii K; Yorozuya K; Mouri Y; Kousaka J; Fukutomi T; Kimura J; Ishiguchi T; Ohno K; Mizumoto T; Harao M
Jpn J Clin Oncol; 2009 Sep; 39(9):552-9. PubMed ID: 19654132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
